請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99342完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳沛隆 | zh_TW |
| dc.contributor.advisor | Pei-Lung Chen | en |
| dc.contributor.author | 呂育璇 | zh_TW |
| dc.contributor.author | Yue-Sheng Lu | en |
| dc.date.accessioned | 2025-09-09T16:05:37Z | - |
| dc.date.available | 2025-09-10 | - |
| dc.date.copyright | 2025-09-09 | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2025-07-24 | - |
| dc.identifier.citation | 1. Morton, C.C. and W.E. Nance, Current concepts: Newborn hearing screening - A silent revolution. New England Journal of Medicine, 2006. 354(20): p. 2151-2164.
2. Wake, M., et al., Slight/mild sensorineural hearing loss in children. Pediatrics, 2006. 118(5): p. 1842-1851. 3. Feder, K.P., et al., Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age. Ear and Hearing, 2017. 38(1): p. 7-20. 4. Dammeyer, J., Psychosocial development in a Danish population of children with cochlear implants and deaf and hard-of-hearing children. Journal of deaf studies and deaf education, 2010. 15(1): p. 50-58. 5. Werfel, K.L., G. Reynolds, and L. Fitton, Oral language acquisition in preschool children who are deaf and hard-of-hearing. Journal of Deaf Studies and Deaf Education, 2022. 27(2): p. 166-178. 6. Onoda, R.M., M.F. de Azevedo, and A.M.N. dos Santos, Neonatal Hearing Screening: failures, hearing loss and risk indicators. Brazilian journal of otorhinolaryngology, 2011. 77(6): p. 775-783. 7. DiStefano, M.T., et al., ClinGen expert clinical validity curation of 164 hearing loss gene–disease pairs. Genetics in Medicine, 2019. 21(10): p. 2239-2247. 8. Delmaghani, S. and A. El-Amraoui, Inner ear gene therapies take off: current promises and future challenges. Journal of clinical medicine, 2020. 9(7): p. 2309. 9. Hilgert, N., R.J. Smith, and G. Van Camp, Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutation Research/Reviews in Mutation Research, 2009. 681(2-3): p. 189-196. 10. Holt, R.A. and S.J. Jones, The new paradigm of flow cell sequencing. Genome research, 2008. 18(6): p. 839-846. 11. Shendure, J., et al., DNA sequencing at 40: past, present and future. Nature, 2017. 550(7676): p. 345-353. 12. Morey, M., et al., A glimpse into past, present, and future DNA sequencing. Molecular genetics and metabolism, 2013. 110(1-2): p. 3-24. 13. Reuter, J.A., D.V. Spacek, and M.P. Snyder, High-throughput sequencing technologies. Molecular cell, 2015. 58(4): p. 586-597. 14. Wu, C.-C., et al., Application of massively parallel sequencing to genetic diagnosis in multiplex families with idiopathic sensorineural hearing impairment. PloS one, 2013. 8(2): p. e57369. 15. Yang, Y., et al., Clinical whole-exome sequencing for the diagnosis of mendelian disorders. New England Journal of Medicine, 2013. 369(16): p. 1502-1511. 16. Tetreault, M., et al., Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities. Expert review of molecular diagnostics, 2015. 15(6): p. 749-760. 17. Li, H. and R. Durbin, Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics, 2010. 26(5): p. 589-595. 18. McKenna, A., et al., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research, 2010. 20(9): p. 1297-1303. 19. Poplin, R., et al., Scaling accurate genetic variant discovery to tens of thousands of samples. BioRxiv, 2018: p. 201178. 20. Wang, K., M. Li, and H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research, 2010. 38(16): p. e164-e164. 21. Tsukada, K., et al., Ethnic-specific spectrum of GJB2 and SLC26A4 mutations: their origin and a literature review. Annals of Otology, Rhinology & Laryngology, 2015. 124(1_suppl): p. 61S-76S. 22. Adzhubei, I.A., et al., A method and server for predicting damaging missense mutations. Nature methods, 2010. 7(4): p. 248-249. 23. Ng, P.C. and S. Henikoff, SIFT: Predicting amino acid changes that affect protein function. Nucleic acids research, 2003. 31(13): p. 3812-3814. 24. Rentzsch, P., et al., CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic acids research, 2019. 47(D1): p. D886-D894. 25. Quang, D., Y. Chen, and X. Xie, DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics, 2015. 31(5): p. 761-763. 26. Jaganathan, K., et al., Predicting splicing from primary sequence with deep learning. Cell, 2019. 176(3): p. 535-548. e24. 27. Richards, S., et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine, 2015. 17(5): p. 405-423. 28. Oza, A.M., et al., Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss. Human mutation, 2018. 39(11): p. 1593-1613. 29. Wu, C.C., et al., Genetic Epidemiology and Clinical Features of Hereditary Hearing Impairment in the Taiwanese Population. Genes, 2019. 10(10): p. 20. 30. Solomon, B.D., et al., Clinical genomic database. Proceedings of the National Academy of Sciences, 2013. 110(24): p. 9851-9855. 31. Azaiez, H., et al., Genomic landscape and mutational signatures of deafness-associated genes. The American Journal of Human Genetics, 2018. 103(4): p. 484-497. 32. Stark, Z., et al., Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. The American Journal of Human Genetics, 2021. 33. Taylor, R.W. and D.M. Turnbull, Mitochondrial DNA mutations in human disease. Nature Reviews Genetics, 2005. 6(5): p. 389-402. 34. Psarommatis, I., et al., Audiologic evaluation of infants and preschoolers: A practical approach. American journal of otolaryngology, 2007. 28(6): p. 392-396. 35. Usami, S.-i., et al., Etiology of single-sided deafness and asymmetrical hearing loss. Acta oto-laryngologica, 2017. 137(sup565): p. S2-S7. 36. Tahir, E., et al., Inner-ear malformations as a cause of single-sided deafness. The Journal of Laryngology & Otology, 2020. 134(6): p. 509-518. 37. Frei, K., et al., Connexin 26 mutations in cases of sensorineural deafness in eastern Austria. European Journal of Human Genetics, 2002. 10(7): p. 427-432. 38. Gürtler, N., et al., GJB2 mutations in the Swiss hearing impaired. Ear and hearing, 2003. 24(5): p. 440-447. 39. Stinckens, C., et al., Longitudinal phenotypic analysis in patients with connexin 26 (GJB2)(DFNB1) and connexin 30 (GJB6) mutations. Annals of Otology, Rhinology & Laryngology, 2004. 113(7): p. 587-593. 40. Morell, R.J., et al., Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. New England Journal of Medicine, 1998. 339(21): p. 1500-1505. 41. Abe, S., et al., Prevalent connexin 26 gene (GJB2) mutations in Japanese. Journal of medical genetics, 2000. 37(1): p. 41-43. 42. Hwa, H.-L., et al., Mutation spectrum of the connexin 26 (GJB2) gene in Taiwanese patients with prelingual deafness. Genetics in Medicine, 2003. 5(3): p. 161-165. 43. Park, H.J., et al., Connexin26 mutations associated with nonsyndromic hearing loss. The Laryngoscope, 2000. 110(9): p. 1535-1538. 44. Mahdieh, N., et al., The frequency of GJB2 mutations and the Δ (GJB6‐D13S1830) deletion as a cause of autosomal recessive non‐syndromic deafness in the Kurdish population. Clinical genetics, 2004. 65(6): p. 506-508. 45. Sirmaci, A., D. Akcayoz-Duman, and M. Tekin, The c. IVS1+ 1G> A mutation inthe GJB2 gene is prevalent and large deletions involving the GJB6 gene are not present in the Turkish population. Journal of Genetics, 2006. 85(3). 46. Bajaj, Y., et al., Spectrum of GJB2 mutations causing deafness in the British Bangladeshi population. Clinical Otolaryngology, 2008. 33(4): p. 313-318. 47. Padma, G., et al., GJB2 and GJB6 gene mutations found in Indian probands with congenital hearing impairment. Journal of genetics, 2009. 88: p. 267-272. 48. Campbell, C., et al., Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype–phenotype correlations. Human mutation, 2001. 17(5): p. 403-411. 49. Coyle, B., et al., Molecular analysis of the PDS gene in Pendred syndrome (sensorineural hearing loss and goitre). Human Molecular Genetics, 1998. 7(7): p. 1105-1112. 50. Park, H.J., et al., Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans. Clinical genetics, 2005. 67(2): p. 160-165. 51. Tsukamoto, K., et al., Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. European journal of human genetics, 2003. 11(12): p. 916-922. 52. Wu, C.C., et al., Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation. The Laryngoscope, 2005. 115(6): p. 1060-1064. 53. Dai, P., et al., SLC26A4 c. 919-2A> G varies among Chinese ethnic groups as a cause of hearing loss. Genetics in Medicine, 2008. 10(8): p. 586-592. 54. Dai, P., et al., Molecular etiology of hearing impairment in Inner Mongolia: mutations in SLC26A4 gene and relevant phenotype analysis. Journal of translational medicine, 2008. 6: p. 1-12. 55. Yang, X.-L., et al., Common molecular etiology of patients with nonsyndromic hearing loss in Tibetan, Tu nationality, and Mongolian patients in the northwest of China. Acta Oto-Laryngologica, 2013. 133(9): p. 930-934. 56. Liu, Y., et al., Genetic frequencies related to severe or profound sensorineural hearing loss in Inner Mongolia Autonomous Region. Genetics and Molecular Biology, 2016. 39(4): p. 567-572. 57. Tekin, M., et al., GJB2 mutations in Mongolia: complex alleles, low frequency, and reduced fitness of the deaf. Annals of human genetics, 2010. 74(2): p. 155-164. 58. Zerjal, T., et al., The genetic legacy of the Mongols. The American Journal of Human Genetics, 2003. 72(3): p. 717-721. 59. Merriwether, D.A., et al., mtDNA variation indicates Mongolia may have been the source for the founding population for the New World. American Journal of Human Genetics, 1996. 59(1): p. 204. 60. Kolman, C.J., N. Sambuughin, and E. Bermingham, Mitochondrial DNA analysis of Mongolian populations and implications for the origin of New World founders. Genetics, 1996. 142(4): p. 1321-1334. 61. Bai, H., et al., The genome of a Mongolian individual reveals the genetic imprints of Mongolians on modern human populations. Genome biology and evolution, 2014. 6(12): p. 3122-3136. 62. Erdenechuluun, J., et al., Unique spectra of deafness-associated mutations in Mongolians provide insights into the genetic relationships among Eurasian populations. PLoS One, 2018. 13(12): p. e0209797. 63. Shearer, A.E., et al., Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proceedings of the National Academy of Sciences, 2010. 107(49): p. 21104-21109. 64. Brownstein, Z., et al., Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome biology, 2011. 12: p. 1-11. 65. Berensmeier, S., Magnetic particles for the separation and purification of nucleic acids. Applied microbiology and biotechnology, 2006. 73: p. 495-504. 66. Danilchenko, V.Y., et al., Different rates of the SLC26A4-related hearing loss in two indigenous peoples of southern Siberia (Russia). Diagnostics, 2021. 11(12): p. 2378. 67. Park, H., et al., Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. Journal of medical genetics, 2003. 40(4): p. 242-248. 68. Tekin, M., et al., Screening the SLC26A4 gene in probands with deafness and goiter (Pendred syndrome) ascertained from a large group of students of the schools for the deaf in Turkey. Clinical genetics, 2003. 64(4). 69. Azadegan-Dehkordi, F., et al., A novel variant of SLC26A4 and first report of the c. 716T> A variant in Iranian pedigrees with non-syndromic sensorineural hearing loss. American Journal of Otolaryngology, 2018. 39(6): p. 719-725. 70. Song, J., et al., Hearing loss in Waardenburg syndrome: a systematic review. Clinical genetics, 2016. 89(4): p. 416-425. 71. Tassabehji, M., et al., The mutational spectrum in Waardenburg syndrome. Human molecular genetics, 1995. 4(11): p. 2131-2137. 72. Somashekar, P.H., et al., Phenotypic diversity and genetic complexity of PAX3‐related Waardenburg syndrome. American Journal of Medical Genetics Part A, 2020. 182(12): p. 2951-2958. 73. Nasirshalal, M., et al., Identification of a novel heterozygous mutation in the MITF gene in an Iranian family with Waardenburg syndrome type II using next‐generation sequencing. Journal of Clinical Laboratory Analysis, 2021. 35(6): p. e23792. 74. Sánchez-Martín, M., et al., SLUG (SNAI2) deletions in patients with Waardenburg disease. Human molecular genetics, 2002. 11(25): p. 3231-3236. 75. Loupe, J., S. Sampath, and Y. Lacassie, Familial co-segregation of Coffin–Lowry syndrome inherited from the mother and autosomal dominant Waardenburg type IV syndrome due to deletion of EDNRB inherited from the father. European Journal of Medical Genetics, 2014. 57(10): p. 562-566. 76. Luquetti, D.V., et al., Microtia: epidemiology and genetics. American Journal of Medical Genetics Part A, 2012. 158(1): p. 124-139. 77. Alasti, F. and G. Van Camp, Genetics of microtia and associated syndromes. Journal of medical genetics, 2009. 46(6): p. 361-369. 78. Kim, M.-A., et al., Genetic analysis of genes related to tight junction function in the Korean population with non-syndromic hearing loss. PLoS One, 2014. 9(4): p. e95646. 79. Usami, S. and S. Nishio, Nonsyndromic hearing loss and deafness, mitochondrial. 2018. 80. Matsushima, K., et al., High-level heteroplasmy for the m. 7445A> G mitochondrial DNA mutation can cause progressive sensorineural hearing loss in infancy. International Journal of Pediatric Otorhinolaryngology, 2018. 108: p. 125-131. 81. Elmaleh-Bergès, M., et al., Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations. American Journal of Neuroradiology, 2013. 34(6): p. 1257-1263. 82. Ho, S.S., A.E. Urban, and R.E. Mills, Structural variation in the sequencing era. Nature Reviews Genetics, 2020. 21(3): p. 171-189. 83. Mandelker, D., et al., Comprehensive diagnostic testing for stereocilin: an approach for analyzing medically important genes with high homology. The Journal of Molecular Diagnostics, 2014. 16(6): p. 639-647. 84. Shearer, A.E., et al., Copy number variants are a common cause of non-syndromic hearing loss. Genome medicine, 2014. 6: p. 1-10. 85. Laurent, S., et al., Molecular characterization of pathogenic OTOA gene conversions in hearing loss patients. Human mutation, 2021. 42(4): p. 373-377. 86. Belkadi, A., et al., Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proceedings of the National Academy of Sciences, 2015. 112(17): p. 5473-5478. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99342 | - |
| dc.description.abstract | 全球每1000名新生兒就有2名新生兒有聽損狀況，此篇研究統計2022年至2024年間，針對460位台灣個案(含422位聽損個案及38位聽力正常個案)進行聽損基因檢測的成果與發現，另外選取101個蒙古個案(含97位聽損個案及4位聽力正常個案)做聽損基因的研究，並比較台灣與蒙古人之間聽損基因的差異，最後再討論遺傳諮詢對於聽損次世代基因定序的幫助及必要性。
此研究針對台灣422位聽損個案進行次世代定序基因篩檢，基因確診率為43.8%，基因確診人數最多的基因為GJB2，佔59%，其次為SLC26A4和MYO15A。研究團隊也依據近年來的統計結果，更新了聽損次世代定序目標基因變異檢測-小範圍基因名單，預計能提高致病變異的檢出率。 蒙古97位聽損個案進行次世代定序基因篩檢，基因確診率為43.2 %，確診人數最多的基因為SLC26A4，再來為GJB2，與先前研究結果順序對調，而且熱門變異位點(Hotspot)也不盡相同。研究中可以看出台灣人與蒙古人之間聽損基因的差異，深受地理環境及歷史因素影響，從而發展出屬於各自族群的聽損基因光譜。 隨著基因檢測的普及，遺傳諮詢近年逐漸被重視，不再只是給予一張報告了事，而應該從檢驗前的諮詢，檢驗中的分析，到檢驗後的報告解釋都要完整提供，本研究案提供多個諮詢範例來解釋遺傳諮詢的作用及重要性。 次世代定序檢測為許多遺傳性聽損個案找到造成聽損原因，但仍有其侷限之處，未來再針對未基因確診個案做進一步分析，以期找到致病原因。 | zh_TW |
| dc.description.abstract | Two out of every 1,000 newborns in the world have hearing loss. This study counted the results and findings of hearing loss gene testing on 460 Taiwanese cases (including 422 hearing loss cases and 38 normal hearing cases) from 2022 to 2024. In addition, 101 Mongolian cases (including 97 hearing loss cases and 4 normal hearing cases) were selected for hearing loss gene research, and the differences in hearing loss genes between Taiwanese and Mongolians were compared. Finally, the help and necessity of genetic counseling for next-generation gene sequencing of hearing loss were discussed.
This study conducted next-generation sequencing gene screening on 422 hearing loss cases in Taiwan, with a gene diagnosis rate of 43.8%. The gene with the most confirmed cases was GJB2, accounting for 59%, followed by SLC26A4 and MYO15A. The research team also updated the small-scale gene list for hearing loss next-generation sequencing target gene variation detection based on recent statistical results, which is expected to increase the detection rate of pathogenic variation. 97 hearing loss cases in Mongolia were screened by next generation sequencing, and the gene diagnosis rate was 43.2%. The gene with the most confirmed cases was SLC26A4, followed by GJB2, which was reversed from the previous research results, and the hot spots were also different. The study showed that the difference in hearing loss genes between Taiwanese and Mongolians was deeply influenced by geographical environment and historical factors, thus developing hearing loss gene spectra belonging to their respective ethnic groups. With the popularity of genetic testing, genetic counseling has gradually been valued in recent years. It is no longer just a report, but should be fully provided from pre-test consultation, analysis during the test, to post-test report interpretation. This study provides multiple counseling examples to explain the role and importance of genetic counseling. Next-generation sequencing has found the cause of hearing loss for many cases of hereditary hearing loss, but it still has its limitations. In the future, further analysis will be conducted on undiagnosed cases in order to find the cause of the disease. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-09T16:05:37Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2025-09-09T16:05:37Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
謝辭 ii 中文摘要 iii ABSTRACT iv 目 次 vi 圖 次 ix 表 次 x 第一章 緒論 1 1.1 背景 1 1.2 聽損基因檢測 3 第二章 台灣聽損基因分析 4 2.1 簡介 4 2.2 分析方法 5 2.3 聽損次世代定序目標基因變異檢測 Deafness-related targeted NGS 8 2.3.1 聽損次世代定序目標基因變異檢測-大範圍 8 2.3.2 聽損次世代定序目標基因變異檢測-小範圍 8 2.3.3 統計數據 11 2.4 全表現子定序Whole exome sequencing(WES) 12 2.4.1全表現子定序 12 2.4.2 統計數據 12 2.5 結論 14 第三章 蒙古國聽損基因分析 17 3.1 簡介 17 3.2 分析方法 18 3.2.1 臨床評估 18 3.2.2 檢體取得 18 3.2.3 檢體挑選 19 3.2.4 次世代定序檢測平台及方式 20 3.3 統計數據 21 3.3.1 分析結果 21 3.3.2 SLC26A4 27 3.3.3 GJB2 28 3.3.4 瓦登伯格症(Waardenburg Syndrome) 29 3.3.6 有家族史或無症候群之聽損 33 3.4 結論 33 第四章 台灣與蒙古聽損基因比較 35 第五章 遺傳諮詢 37 5.1 諮詢內容 37 5.2 諮詢範例 39 5.3 結論 43 第六章 討論 44 參考文獻 ： 45 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 聽損基因 | zh_TW |
| dc.subject | 次世代定序 | zh_TW |
| dc.subject | 蒙古 | zh_TW |
| dc.subject | Mongolia | en |
| dc.subject | next-generation sequencing | en |
| dc.subject | hearing loss gene | en |
| dc.title | 次世代定序技術於台灣與蒙古聽損基因研究之應用與發現 | zh_TW |
| dc.title | Application and discovery of next-generation sequencing in hearing loss gene research in Taiwan and Mongolia | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 113-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 吳振吉;許書睿 | zh_TW |
| dc.contributor.oralexamcommittee | Chen-Chi Wu ;Shu-Jui Hsu | en |
| dc.subject.keyword | 次世代定序,聽損基因,蒙古, | zh_TW |
| dc.subject.keyword | next-generation sequencing,hearing loss gene,Mongolia, | en |
| dc.relation.page | 54 | - |
| dc.identifier.doi | 10.6342/NTU202502294 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2025-07-24 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 分子醫學研究所 | - |
| dc.date.embargo-lift | 2030-07-22 | - |
| 顯示於系所單位： | 分子醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-113-2.pdf 未授權公開取用 | 1.53 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。